| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.1 | 0.7 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.056 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.057 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |